Vicky Papoutsis Appointed to Continuity Biosciences Board

Continuity Biosciences has appointed Vicky Papoutsis as a new member of its board of directors. The company stated that this appointment aligns with its ongoing efforts to advance its clinical programs and partnership activities.

Papoutsis's background includes significant experience in business development and corporate strategy, which the company believes will be instrumental in guiding its future growth. Her expertise is expected to support Continuity Biosciences as it navigates the complexities of its clinical research and seeks strategic collaborations.

The company's focus remains on the progression of its clinical pipeline and the expansion of its market reach through strategic alliances. The addition of Papoutsis to the board is seen as a move to bolster the leadership team's capabilities in these areas.

Continuity Biosciences is headquartered in Bradenton, Florida. The company is involved in the development of [mention field, e.g., pharmaceutical therapies, medical devices] and aims to address [mention unmet need, e.g., unmet medical needs, specific diseases].